Search
Showing Results For "pharmaceuticals"
 Cipla's arm Medi tab sells stake in Jiangsu for USD 18.5 million

Cipla's arm Medi tab sells stake in Jiangsu for USD 18.5 million

10 Dec 2014

New Delhi: Drug major Cipla on Wednesday said its Mauritius subsidiary Meditab Holdings has signed a deal to sell its entire 48.22 percent stake in China-based Jiangsu Cdymax Pharmaceuticals for USD 18.5 million (over Rs 114 crore).

Cipla,   Mauritius subsidiary,   BSE,   Jiangsu Cdymax Pharmaceuticals,  
Cipla ties up with Serum Institute to market vaccines in Europe

Cipla ties up with Serum Institute to market vaccines in Europe

20 Nov 2014

New Delhi: Pharmaceuticals firm Cipla on Thursday announced an agreement with Serum Institute of India for distribution of paediatric vaccines in Europe.

Pharmaceuticals firm,   Cipla,   Serum Institute of India,   Paediatric vaccines,   Europe,  
Will focus on building ties with India: Nikki Haley

Will focus on building ties with India: Nikki Haley

20 Nov 2014

Mumbai: Indian-origin Governor of the US state of South Carolina, Nikki Haley on Thursday said she is very optimistic about India and will focus on building ties between the two countries.

Indian-origin Governor of the US state,   South Carolina,   Nikki Haley,   focus on building ties between the two countries,   initiated talks with industries,   pharmaceuticals,   manufacturing,   Information Technology,   agriculture,   ,  
Tamil Nadu to hold Global Investors' Meet in May 2015

Tamil Nadu to hold Global Investors' Meet in May 2015

13 Nov 2014

Chennai: The Tamil Nadu government will hold a two-day Global Investors' Meet (GIM) here from May 23, 2015 to showcase the state's potential and also lure investments.

Tamil Nadu government,   two-day,   Global Investors' Meet,   (GIM),   showcase the state's potential and also lure investments,   sectors like electronics,   textiles,   agro,   food processing,   IT/ITES,   biotechnology,   pharmaceuticals,   automobiles,   auto components,  ,  ,   ,  
Indian-origin scientist finds way to develop better drugs

Indian-origin scientist finds way to develop better drugs

26 Aug 2014

New York: An Indian-origin researcher at Michigan Technological University has deciphered how Glycoconjugates-biomolecules that hold sugars in the body like scaffolds for reacting with other molecules, can lead to new and better drugs.

Indian-origin scientist,   drugs,   scaffolds,   drug,   pharmaceuticals,   ,  
Government strips NPPA of powers to cap non-essential drug prices

Government strips NPPA of powers to cap non-essential drug prices

23 Sep 2014

New Delhi: The government has stripped drug pricing authority NPPA of powers to cap prices of non- essential drugs after its recent order triggered industry protests.

Modi government,   Drug pricing authority,   NPPA,   Non- essential drugs,   Pharmaceuticals industry,  
Eight Chinese quarantined as panic grips Ebola-hit West Africa

Eight Chinese quarantined as panic grips Ebola-hit West Africa

12 Aug 2014

Freetown: Eight Chinese medical workers who treated Ebola patients have been quarantined in Sierra Leone, as health experts grapple with ethical questions over the use of experimental drugs to combat the killer virus.

Ebola Epidemic,   China,   ZMapp,   Ebola infections,   Mapp Pharmaceuticals,   Ebola vaccine,  
Supreme Court asks Andhra HC to decide on Ranbaxy-Sun Pharma merger within two days

Supreme Court asks Andhra HC to decide on Ranbaxy-Sun Pharma merger within two days

21 May 2014

New Delhi: The Supreme Court on Wednesday asked the Andhra Pradesh High Court to take a decision within two days on a plea challenging merger of Sun Pharmaceutical with Ranbaxy.

Ranbaxy,   Sun Pharmaceuticals,   Andhra Pradesh high court,   Ranbaxy-Sun Pharma merger,   Supreme Court,   ,  
Ranbaxy Q4 net loss declines sharply to Rs 158.48 crore

Ranbaxy Q4 net loss declines sharply to Rs 158.48 crore

05 Feb 2014

New Delhi: Pharma major Ranbaxy Laboratories on Wednesday reported a drastic drop in net loss at Rs 158.48 crore during the fourth quarter ended December 31, 2013.

Ranbaxy Q4 net loss,   Ranbaxy Laboratories,   Ranbaxy net loss,   Ranbaxy pharmaceuticals,  
US drug probes: Johnson & Johnson to pay USD 2.2 billion

US drug probes: Johnson & Johnson to pay USD 2.2 billion

05 Nov 2013

Washington: In one of the largest health care fraud settlements in US history, Johnson & Johnson will pay USD 2.2 billion to end civil and criminal investigations into kickbacks to pharmacists and the marketing of pharmaceuticals for off-label uses, US Attorney General Eric Holder said on Monday.

health care fraud,   US drug probes,   Johnson & Johnson,   criminal investigations,   pharmaceuticals ,  

1 2  3